5-Oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparagine | CAS No. 63958-90-7
5-Oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparagine
Basic Information
CAS Number
63958-90-7
Molecular Formula
C33H54N12O15
Molecular Weight
858.86 g/mol
AD
Chemical Classification
Basic Physical Properties
Density
1.417±0.06 g/cm3 (20 ºC 760 Torr),
Synonyms & References
English
- nonathymuline
- Thymic factor
- Thymalin
- (3S,6S,9S,12S,21S,24S)-24-(2-amino-2-oxoethyl)-12-(3-amino-3-oxopropyl)-6-(4-aminobutyl)-9,21-bis(hydroxymethyl)-3-methyl-1,4,7,10,13,16,19,22-octaoxo-1-((S)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20,23-octaazapentacosan-25-oic acid
- Thymulin (pig peptide moiety)
- (2S)-4-amino-2-[[(2S)-2-[[2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoic acid
- DTXCID00136292
- SMR000058784
- Thymulin
- SCHEMBL2109423
- MLS000028679
- UNII-9H198D04WL
- CS-0169099
- (sup 2)N-(N-(N-(N-(sup 2)N-(N-(sup 2)N-(N-(-5-Oxo-L-prolyl)-L-alanyl)-L-seryl)-L-glutaminyl)glycyl)glycyl)-L-seryl)-L-asparagine.
- DTXSID10213801
- nonathymulinum
- pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH
- ((S)-5-Oxopyrrolidine-2-carbonyl)-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparagine
- Thymulin Acetate
- HY-P3206
- MFCD00076882
- GLXC-25916
- N(sup 2)-(N-(N-(N-(N(sup 2)-(N-(N(sup 2)-(N-(-5-Oxo-L-prolyl)-L-alanyl)-L-lysyl)-L-seryl)-L-glutaminyl)glycyl)glycyl)-L-seryl)-L-asparagine
- Q2007601
- Thymulin, lyophilized powder
- Nonathymulin [INN]
- NS00123149
- CHEMBL2106455
- Thymuline
- 9H198D04WL
- L-ASPARAGINE, 5-OXO-L-PROLYL-L-ALANYL-L-LYSYL-L-SERYL-L-GLUTAMINYLGLYCYLGLYCYL-L-SERYL-
MDL Number
MFCD00076882
FAQ
What regulatory guidelines apply to 5-Oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparagine (CAS: 63958-90-7)?
The compound 5-Oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparagine (CAS: 63958-90-7) is subject to various regulatory guidelines. Under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), it is classified based on its physical and chemical properties. In the European Union, it must comply with the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation. Additionally, the U.S. Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) have specific requirements for the handling and use of this compound in pharmaceutical and industrial applications.
Are there alternatives to 5-Oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparagine (CAS: 63958-90-7) in synthesis?
There are several alternatives to 5-Oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparagine (CAS: 63958-90-7) in synthesis. These include amino acid analogs such as 5-Oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-aspartic acid, and isomers like 5-Oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparaginylglycine. Common alternative reagents include various coupling agents and chiral catalysts that can facilitate the synthesis of similar peptides or analogs.
What is the market or research trend for 5-Oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparagine (CAS: 63958-90-7)?
The market for 5-Oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparagine (CAS: 63958-90-7) is driven by its applications in pharmaceutical research, particularly in the development of peptide-based drugs. Recent research trends focus on the optimization of synthesis methods and the exploration of its potential in therapeutic areas such as inflammation and pain management. The demand is also influenced by the growing interest in biotechnology and personalized medicine.
How should waste containing 5-Oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparagine (CAS: 63958-90-7) be handled?
Waste containing 5-Oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparagine (CAS: 63958-90-7) should be managed according to regulatory guidelines. Proper waste collection and disposal methods include the use of appropriate containers to prevent contamination. For liquid waste, it should be collected in sealed, labeled containers and disposed of through a licensed waste management facility. Incineration is another disposal method, but it must be performed in a controlled and environmentally safe manner to minimize the release of harmful substances into the environment.
Related Compounds
![N-(2-Methoxyphenyl)-N-[(4-methylphenyl)sulfonyl]-beta-alanine structure](https://static.chemtradehub.com/structs/103/103687-96-3-8086.webp "N-(2-Methoxyphenyl)-N-[(4-methylphenyl)sulfonyl]-beta-alanine structure")
N-(2-Methoxyphenyl)-N-[(4-methylphenyl)sulfonyl]-beta-alanine
CAS Number:
103687-96-3
Molecular Formula:
C17H19NO5S
![5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]cytidine structure](https://static.chemtradehub.com/structs/112/112897-99-1-d1f4.webp "5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]cytidine structure")
5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]cytidine
CAS Number:
112897-99-1
Molecular Formula:
C30H31N3O7
![(3S,4R)-3-Hydroxy-2,2-dimethyl-4-[(3-oxo-1-cyclopenten-1-yl)oxy]-6-chromanecarbonitrile structure](https://static.chemtradehub.com/structs/121/121055-10-5-583d.webp "(3S,4R)-3-Hydroxy-2,2-dimethyl-4-[(3-oxo-1-cyclopenten-1-yl)oxy]-6-chromanecarbonitrile structure")
(3S,4R)-3-Hydroxy-2,2-dimethyl-4-[(3-oxo-1-cyclopenten-1-yl)oxy]-6-chromanecarbonitrile
CAS Number:
121055-10-5
Molecular Formula:
C17H17NO4
![Methyl 5-chloropyrazolo[1,5-a]pyrimidine-2-carboxylate structure](https://static.chemtradehub.com/structs/126/1263059-26-2-d6da.webp "Methyl 5-chloropyrazolo[1,5-a]pyrimidine-2-carboxylate structure")
Methyl 5-chloropyrazolo[1,5-a]pyrimidine-2-carboxylate
CAS Number:
1263059-26-2
Molecular Formula:
C8H6ClN3O2
You might also like
Compound Q&A
What is 6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one (CAS: 21889-89-4)?
6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one is a cyclic ketone with a molecular for...
21889-89-46-Methyl-7-oxabicycl...
Compound Q&A
What is 4-[(6-Methyl-2-pyrazinyl)oxy]benzoic acid (CAS: 906353-00-2)?
4-[(6-Methyl-2-pyrazinyl)oxy]benzoic acid is a chemical compound with the CAS nu...
906353-00-24-[(6-Methyl-2-pyraz...
Compound Q&A
What is 2-(2-Pyridinyl)-1,3-propanediol (CAS: 49745-42-8)?
2-(2-Pyridinyl)-1,3-propanediol (CAS: 49745-42-8) is a colorless to slightly yel...
49745-42-82-(2-Pyridinyl)-1,3-...
Compound Q&A
What is 2-(6-Chloro-2-pyridinyl)-2-phenylacetonitrile (CAS: 24783-42-4)?
2-(6-Chloro-2-pyridinyl)-2-phenylacetonitrile is an organic compound with the CA...
24783-42-42-(6-Chloro-2-pyridi...
Compound Q&A
What is 2-Oxopropanamide (CAS: 631-66-3)?
2-Oxopropanamide, also known as 2-aminoacrylic acid, is a chemical compound with...
631-66-32-Oxopropanamide
Compound Q&A
What is 2-Methyl-2-propanyl 4-(5-bromo-6-methyl-2-pyridinyl)-1-piperazinecarboxylate (CAS: 1289040-88-5)?
2-Methyl-2-propanyl 4-(5-bromo-6-methyl-2-pyridinyl)-1-piperazinecarboxylate (CA...
1289040-88-52-Methyl-2-propanyl ...
Compound Q&A
What is NAMPT inhibitor-linker 1 (CAS: 2241019-57-6)?
NAMPT inhibitor-linker 1 (CAS: 2241019-57-6) is a chemical compound designed as ...
2241019-57-6NAMPT inhibitor-link...
Compound Q&A
What is (2-(2,2,2-Trifluoroacetyl)pyridin-4-yl)boronic acid (CAS: 1310404-58-0)?
It is a chemical compound with the structure (2-(2,2,2-Trifluoroacetyl)pyridin-4...
1310404-58-0(2-(2,2,2-Trifluoroa...
Compound Q&A
What is 1-(2-Chlorophenyl)-6-(3,3,3-trifluoro-2-methylpropyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (CAS: 794568-90-4)?
1-(2-Chlorophenyl)-6-(3,3,3-trifluoro-2-methylpropyl)-1,5-dihydro-4H-pyrazolo[3,...
794568-90-41-(2-Chlorophenyl)-6...
Compound Q&A
What is Vinyl(chloromethyl)dimethoxysilane (CAS: 1314981-48-0)?
Vinyl(chloromethyl)dimethoxysilane is an organosilicon compound with the molecul...
1314981-48-0Vinyl(chloromethyl)d...
